Storage follow-through
NAND demand and memory breadth.
Read the weekly notesOct. 19–23, 2026 · The weekly brief
Tech could bounce back this week.
After last week’s selloff, the recovery needs confirmation.
Research notes, not live quotes
NAND demand and memory breadth.
Read the weekly notes →Margins, reporting and order conversion.
Read the weekly notes →Separate power contracts from deployment risk.
Read the nuclear thesis →Weekly overview & archive
Oct. 19–23 · reviewed Oct. 19 · all times Eastern
Current issue. Use the weekly archive above to review how the market focus and playbook changed over time.
Open the MU thesis for dated reported results, guidance and risks.
Distinguish financial results from guidance and preliminary reporting. Full weekly notes load with the research dashboard.
Will's watchlist · conviction & execution
A focused weekly lane for the stocks that matter most to my current view—separate from the full sector board, with the timeline, setup, thesis, and risk laid out before any opinion becomes conviction.
Memory leadership, storage follow-through, AI-server execution, NVIDIA shareholder returns, and nuclear confirmation
Oct. 19 premarket review: MU remains my highest-conviction long-term memory idea. Last week’s selling means tactical confirmation matters: a defended reclaim, a higher low and SMH participation. SNDK remains the NAND/storage watch; WDC reports Oct. 22, while SNDK’s own call is Oct. 29. SMCI remains featured in place of CSCO, with margins, cash conversion and reporting quality central to the thesis. Nuclear stays secondary until price, volume and group breadth confirm.
New: read the TSM swing thesis →
New swing research · TSM · reviewed Oct. 19, 2026
Taiwan Semiconductor Manufacturing · value-oriented watch · confirmation required
TSMC’s leading-edge manufacturing and packaging support advanced chips. In its Oct. 15 call, management said assessed demand exceeds supply and it is expanding capacity to narrow the gap.
I see a potential value-oriented swing after the selloff. Strong results make TSM worth researching; the decline alone does not establish fair value. No formal fair-value estimate or verified forward P/E is asserted here.
Watch the $421.50–$423.66 prior-high area for a defended retest and higher low with SMH / QQQ support. $440.39 and $445.50 are historical resistance references, not promised targets. Avoid chasing an extended bounce.
Price context: Oct. 16 close $412.61; down 8.98% from Oct. 9 close $453.31. Oct. 19 snapshot: $425.66 at 11:18 a.m. ET, up 3.16% from Friday. These are dated references, not a streaming quote.
What would weaken the swing: a failed reclaim or loss of the newly defended higher low. $410.58 and $407.13 are Oct. 16 and Oct. 15 lows, respectively; using a broad stop that far away may leave insufficient reward relative to risk. Position size and invalidation require a current chart.
Business risks: Taiwan geopolitical exposure, customer capital-spending cycles, export restrictions and overseas-fab / new-node costs. Management also flagged pressure in consumer and price-sensitive markets. Supply constraints can limit sales; strong AI demand does not eliminate downside.
Financial period: quarter ended Sept. 30, 2026; reported Oct. 15. USD revenue growth differs from the 50.9% growth reported in Taiwan dollars. Sources: SEC-filed earnings release · Company-hosted earnings transcript · Dated market prices. This supplemental swing watch is not assigned a confidence score or included in the rated sector-board average.
Research lane map
Four priority research themes. Eleven market sectors. Select a lane to examine its thesis, evidence and risks.
Research board
Filter by stance, confidence, ticker, or sector. Open any card for the full thesis, price scenarios, catalyst, risk, and latest weekly update.
Research, not noise
Review the highest-conviction ideas, compare risk and reward, and use the dated methodology to see exactly what would strengthen—or invalidate—each outlook.
Research methodology
Every published opinion follows the same structure so readers can separate evidence, expectation, and risk.
Revenue durability, margins, balance-sheet strength, cash generation, competitive position, and management execution.
What expectations are already priced in, compared with growth, profitability, risk, and credible peer benchmarks.
The specific developments that could move the thesis forward—and the evidence that would invalidate it.
Confidence, stance, targets, and thesis changes are dated so every update can be judged against the prior view.